Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma

Gangadhara R. Sareddy(The University of Texas Health Science Center at San Antonio), Ratna K. Vadlamudi(The University of Texas at San Antonio Health Science Center)
Scientific Reports
April 29, 2016
10.1038/srep24185
Cited by 71

Related Papers

Functional Interactions between the Estrogen Receptor Coactivator PELP1/MNAR and Retinoblastoma Protein
|Journal of Biological Chemistry|2003|90
Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
|Breast Cancer Research|2012|82
PELP1 oncogenic functions involve CARM1 regulation
|Carcinogenesis|2013|70
Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer
|Oncotarget|2017|43
Proline, glutamic acid and leucine-rich protein-1 is essential for optimal p53-mediated DNA damage response
|Cell Death and Differentiation|2014|33